Hongqiang Cheng Selected Research

Non-Receptor Type 11 Protein Tyrosine Phosphatase

3/2022	Endothelial Shp2 deficiency controls alternative activation of macrophage preventing radiation-induced lung injury through notch signaling.
1/2019	Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10.
9/2014	Myeloid-specific disruption of tyrosine phosphatase Shp2 promotes alternative activation of macrophages and predisposes mice to pulmonary fibrosis.
6/2012	Loss of Shp2 in alveoli epithelia induces deregulated surfactant homeostasis, resulting in spontaneous pulmonary fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongqiang Cheng Research Topics

Disease

6	Inflammation (Inflammations) 01/2021 - 06/2012
5	Neoplasms (Cancer) 11/2021 - 04/2010
5	Cardiomyopathies (Cardiomyopathy) 10/2019 - 02/2009
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 06/2012
4	Heart Failure 10/2013 - 02/2009
3	Wounds and Injuries (Trauma) 01/2020 - 11/2016
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2019 - 08/2010
2	Lung Injury 03/2022 - 12/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 01/2019
2	Vascular Remodeling 01/2020 - 12/2019
2	Neointima 01/2020 - 12/2019
2	Asthma (Bronchial Asthma) 11/2016 - 01/2016
2	Heart Diseases (Heart Disease) 04/2012 - 04/2010
1	Acute Lung Injury 12/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Thrombosis (Thrombus) 11/2020
1	Vascular System Injuries 01/2020
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 12/2019
1	LEOPARD Syndrome (Syndrome, LEOPARD) 12/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018
1	Xerostomia 01/2018
1	Pulmonary Emphysema 10/2017
1	Emphysema 10/2017
1	Idiopathic Pulmonary Fibrosis 01/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2016
1	Pneumonia (Pneumonitis) 12/2016
1	Naxos disease 04/2015
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2015
1	Pulmonary Arterial Hypertension 03/2015
1	Schistosomiasis (Bilharziasis) 09/2014
1	Cardiac Arrhythmias (Arrythmia) 02/2013
1	Hyperplasia 11/2012
1	Muscular Diseases (Myopathy) 05/2011
1	Bipolar Disorder (Manic Depressive Psychosis) 04/2010
1	Cardiomegaly (Heart Hypertrophy) 05/2009

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2009
4	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 03/2022 - 06/2012
4	Tyrosine (L-Tyrosine)FDA Link 10/2017 - 06/2012
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 09/2014
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 10/2017
3	Protein Tyrosine PhosphatasesIBA 12/2019 - 12/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 10/2020
2	CytokinesIBA 01/2019 - 01/2016
2	Surface-Active Agents (Surfactants)IBA 12/2016 - 06/2012
2	Biological ProductsIBA 01/2016 - 04/2010
1	EnzymesIBA 12/2021
1	T Cell Transcription Factor 1IBA 11/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	IntegrinsIBA 11/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Leucine-Rich Repeat ProteinsIBA 01/2020
1	CollagenIBA 12/2019
1	tanyu tongzhi formulaIBA 03/2019
1	Epidermal Growth Factor (EGF)IBA 03/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 10/2017
1	Pancreatic Elastase (Elastase)IBA 10/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	Pharmaceutical PreparationsIBA 11/2016
1	GlucocorticoidsIBA 01/2016
1	gamma Catenin (Plakoglobin)IBA 04/2015
1	MicroRNAs (MicroRNA)IBA 03/2015
1	ChitinIBA 09/2014
1	Estrogens (Estrogen)FDA Link 10/2013
1	DNA (Deoxyribonucleic Acid)IBA 10/2013
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2013
1	MucinsIBA 11/2012
1	Myosins (Myosin)IBA 04/2012
1	CalcineurinIBA 05/2011
1	Protein Isoforms (Isoforms)IBA 05/2011
1	Protein Kinase CIBA 05/2011
1	LIM Domain ProteinsIBA 04/2010
1	Phosphotransferases (Kinase)IBA 05/2009
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 05/2009
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 05/2009
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 05/2009
1	Cytoskeletal ProteinsIBA 02/2009

Therapy/Procedure

2	Radiotherapy 03/2022 - 01/2018
2	Ligation 01/2020 - 12/2019
1	Therapeutics 11/2021